FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway
Hui, Xuejun, Hu, Fengjiao, Liu, Jia, Li, Changhai, Yang, Yang, Shu, Shangzhi, Liu, Peipei, Wang, Fan, Li, ShuyanJournal:
Journal of Molecular and Cellular Cardiology
DOI:
10.1016/j.yjmcc.2020.09.008
Date:
September, 2020
File:
PDF, 10.35 MB
2020